Sign in
4

Changes in Ownership

ENDONOVO THERAPEUTICS, INC. Filed Acc 0001645470-19-000005

CEO bought 65,500 shares at an average $0.03 ($1,774)

From the SEC's structured data for this filing

Trades in this filing

Table I: Non-derivative

Insider Date Transaction Shares Price Value Owned after D/I
Collier Alan Brian CEO 2019-01-17 Purchase +5,000 $0.03 $149 20,812,623 D: show line 1 in the form
Collier Alan Brian CEO 2019-01-17 Purchase +5,000 $0.03 $148 20,817,623 D: show line 2 in the form
Collier Alan Brian CEO 2019-01-17 Purchase +5,000 $0.03 $148 20,822,623 D: show line 3 in the form
Collier Alan Brian CEO 2019-01-22 Purchase +500 $0.03 $13 20,823,123 D: show line 4 in the form
Collier Alan Brian CEO 2019-01-22 Purchase +10,000 $0.03 $260 20,833,123 D: show line 5 in the form
Collier Alan Brian CEO 2019-01-22 Purchase +5,000 $0.03 $130 20,838,123 D: show line 6 in the form
Collier Alan Brian CEO 2019-01-22 Purchase +5,000 $0.03 $130 20,843,123 D: show line 7 in the form
Collier Alan Brian CEO 2019-01-22 Purchase +5,000 $0.03 $130 20,848,123 D: show line 8 in the form
Open-market purchases · 65,500 sh · avg $0.03 · $1,774
Loading xslF345X03/primary_doc.xml…